8XW Stock Overview
Bridgepoint Group plc is private equity and private credit firm specializing in middle market, lower mid cap, small cap, growth capital and buyouts investment.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 5/6 |
Past Performance | 1/6 |
Financial Health | 6/6 |
Dividends | 2/6 |
Rewards
Risk Analysis
Bridgepoint Group plc Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | UK£2.68 |
52 Week High | UK£3.35 |
52 Week Low | UK£1.92 |
Beta | 1.64 |
1 Month Change | -4.29% |
3 Month Change | -13.77% |
1 Year Change | -0.59% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -53.70% |
Recent News & Updates
Recent updates
Shareholder Returns
8XW | DE Capital Markets | DE Market | |
---|---|---|---|
7D | 2.3% | -2.2% | -1.0% |
1Y | -0.6% | 22.1% | 2.0% |
Return vs Industry: 8XW underperformed the German Capital Markets industry which returned 22.2% over the past year.
Return vs Market: 8XW underperformed the German Market which returned 2% over the past year.
Price Volatility
8XW volatility | |
---|---|
8XW Average Weekly Movement | 5.1% |
Capital Markets Industry Average Movement | 4.7% |
Market Average Movement | 4.9% |
10% most volatile stocks in DE Market | 10.2% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 8XW has not had significant price volatility in the past 3 months.
Volatility Over Time: 8XW's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1985 | 391 | Jonathan Hughes | www.bridgepoint.eu |
Bridgepoint Group plc is private equity and private credit firm specializing in middle market, lower mid cap, small cap, growth capital and buyouts investment. It prefers to invest in advanced industrials, automation, agricultural sciences, energy transition enablers, business services, financial services, professional services, testing inspection and certification, information services, consumer, digital brands, video games, wellbeing products, health care, pharma and MedTech outsourced services, pharma products, and MedTech Products sectors. The firm prefers to invest companies based in United Kingdom, New York and Nordic region.
Bridgepoint Group plc Fundamentals Summary
8XW fundamental statistics | |
---|---|
Market cap | €2.14b |
Earnings (TTM) | €82.41m |
Revenue (TTM) | €374.87m |
25.9x
P/E Ratio5.7x
P/S RatioIs 8XW overvalued?
See Fair Value and valuation analysisEarnings & Revenue
8XW income statement (TTM) | |
---|---|
Revenue | UK£321.60m |
Cost of Revenue | UK£131.60m |
Gross Profit | UK£190.00m |
Other Expenses | UK£119.30m |
Earnings | UK£70.70m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 0.089 |
Gross Margin | 59.08% |
Net Profit Margin | 21.98% |
Debt/Equity Ratio | 4.0% |
How did 8XW perform over the long term?
See historical performance and comparison